nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—TOP1—ovarian cancer	0.453	1	CbGaD
Lucanthone—TOP1—Topotecan—ovarian cancer	0.361	0.836	CbGbCtD
Lucanthone—TOP2A—Epirubicin—ovarian cancer	0.0463	0.107	CbGbCtD
Lucanthone—TOP2A—Doxorubicin—ovarian cancer	0.0246	0.057	CbGbCtD
Lucanthone—APEX1—Homologous Recombination Repair—BRIP1—ovarian cancer	0.00312	0.0466	CbGpPWpGaD
Lucanthone—APEX1—myometrium—ovarian cancer	0.0027	0.0595	CbGeAlD
Lucanthone—APEX1—embryo—ovarian cancer	0.0026	0.0572	CbGeAlD
Lucanthone—APEX1—Double-Strand Break Repair—BRIP1—ovarian cancer	0.00245	0.0366	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MSH2—ovarian cancer	0.00237	0.0353	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MSH2—ovarian cancer	0.00237	0.0353	CbGpPWpGaD
Lucanthone—APEX1—MMR—MSH2—ovarian cancer	0.00225	0.0335	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MLH1—ovarian cancer	0.00213	0.0318	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MLH1—ovarian cancer	0.00213	0.0318	CbGpPWpGaD
Lucanthone—APEX1—epithelium—ovarian cancer	0.00212	0.0467	CbGeAlD
Lucanthone—APEX1—uterine cervix—ovarian cancer	0.0021	0.0463	CbGeAlD
Lucanthone—APEX1—MMR—MLH1—ovarian cancer	0.00203	0.0302	CbGpPWpGaD
Lucanthone—APEX1—decidua—ovarian cancer	0.00201	0.0441	CbGeAlD
Lucanthone—APEX1—endometrium—ovarian cancer	0.0019	0.0419	CbGeAlD
Lucanthone—TOP1—myometrium—ovarian cancer	0.00189	0.0416	CbGeAlD
Lucanthone—APEX1—gonad—ovarian cancer	0.00177	0.0388	CbGeAlD
Lucanthone—APEX1—uterus—ovarian cancer	0.00175	0.0386	CbGeAlD
Lucanthone—APEX1—Chromosome Maintenance—RSF1—ovarian cancer	0.00167	0.025	CbGpPWpGaD
Lucanthone—APEX1—female reproductive system—ovarian cancer	0.00158	0.0347	CbGeAlD
Lucanthone—APEX1—bone marrow—ovarian cancer	0.00149	0.0327	CbGeAlD
Lucanthone—TOP1—uterine cervix—ovarian cancer	0.00147	0.0324	CbGeAlD
Lucanthone—APEX1—Homologous Recombination Repair—BRCA1—ovarian cancer	0.00146	0.0218	CbGpPWpGaD
Lucanthone—APEX1—female gonad—ovarian cancer	0.00143	0.0316	CbGeAlD
Lucanthone—APEX1—vagina—ovarian cancer	0.00143	0.0314	CbGeAlD
Lucanthone—TOP1—decidua—ovarian cancer	0.0014	0.0309	CbGeAlD
Lucanthone—APEX1—TSH signaling pathway—TTF1—ovarian cancer	0.00137	0.0204	CbGpPWpGaD
Lucanthone—APEX1—Global Genomic NER (GG-NER)—ERCC1—ovarian cancer	0.00136	0.0203	CbGpPWpGaD
Lucanthone—TOP2A—myometrium—ovarian cancer	0.00135	0.0296	CbGeAlD
Lucanthone—TOP1—endometrium—ovarian cancer	0.00133	0.0293	CbGeAlD
Lucanthone—APEX1—Homologous Recombination Repair—BRCA2—ovarian cancer	0.00132	0.0197	CbGpPWpGaD
Lucanthone—APEX1—testis—ovarian cancer	0.00127	0.028	CbGeAlD
Lucanthone—TOP1—uterus—ovarian cancer	0.00123	0.027	CbGeAlD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—XIAP—ovarian cancer	0.00115	0.0172	CbGpPWpGaD
Lucanthone—APEX1—Double-Strand Break Repair—BRCA1—ovarian cancer	0.00115	0.0171	CbGpPWpGaD
Lucanthone—APEX1—Transcription-coupled NER (TC-NER)—ERCC1—ovarian cancer	0.00109	0.0162	CbGpPWpGaD
Lucanthone—TOP2A—uterine cervix—ovarian cancer	0.00105	0.0231	CbGeAlD
Lucanthone—TOP1—bone marrow—ovarian cancer	0.00104	0.0229	CbGeAlD
Lucanthone—APEX1—Double-Strand Break Repair—BRCA2—ovarian cancer	0.00104	0.0155	CbGpPWpGaD
Lucanthone—TOP1—female gonad—ovarian cancer	0.001	0.0221	CbGeAlD
Lucanthone—TOP2A—decidua—ovarian cancer	0.000999	0.022	CbGeAlD
Lucanthone—APEX1—Nucleotide Excision Repair—ERCC1—ovarian cancer	0.000998	0.0149	CbGpPWpGaD
Lucanthone—TOP1—vagina—ovarian cancer	0.000998	0.022	CbGeAlD
Lucanthone—TOP2A—G0 and Early G1—RBL2—ovarian cancer	0.000974	0.0145	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RBL2—ovarian cancer	0.000969	0.0144	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—PARP1—ovarian cancer	0.000956	0.0143	CbGpPWpGaD
Lucanthone—TOP2A—endometrium—ovarian cancer	0.000948	0.0209	CbGeAlD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—TNFSF10—ovarian cancer	0.000945	0.0141	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000937	0.014	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—SLC2A1—ovarian cancer	0.000932	0.0139	CbGpPWpGaD
Lucanthone—APEX1—lymph node—ovarian cancer	0.000922	0.0203	CbGeAlD
Lucanthone—TOP1—testis—ovarian cancer	0.00089	0.0196	CbGeAlD
Lucanthone—TOP2A—uterus—ovarian cancer	0.000873	0.0192	CbGeAlD
Lucanthone—APEX1—DNA Repair—PALB2—ovarian cancer	0.000785	0.0117	CbGpPWpGaD
Lucanthone—TOP2A—bone marrow—ovarian cancer	0.000741	0.0163	CbGeAlD
Lucanthone—APEX1—Extension of Telomeres—TERT—ovarian cancer	0.000715	0.0107	CbGpPWpGaD
Lucanthone—TOP2A—female gonad—ovarian cancer	0.000715	0.0157	CbGeAlD
Lucanthone—TOP2A—vagina—ovarian cancer	0.00071	0.0156	CbGeAlD
Lucanthone—APEX1—DNA Repair—BRIP1—ovarian cancer	0.000686	0.0102	CbGpPWpGaD
Lucanthone—TOP1—lymph node—ovarian cancer	0.000645	0.0142	CbGeAlD
Lucanthone—TOP1—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000641	0.00955	CbGpPWpGaD
Lucanthone—TOP2A—testis—ovarian cancer	0.000634	0.0139	CbGeAlD
Lucanthone—TOP1—Circadian rythm related genes—HNF1B—ovarian cancer	0.000556	0.00828	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TP63—ovarian cancer	0.000522	0.00778	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—ERCC1—ovarian cancer	0.00052	0.00775	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—BARD1—ovarian cancer	0.000489	0.0073	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—MSH2—ovarian cancer	0.00047	0.00701	CbGpPWpGaD
Lucanthone—TOP2A—lymph node—ovarian cancer	0.000459	0.0101	CbGeAlD
Lucanthone—TOP2A—G0 and Early G1—CCNE1—ovarian cancer	0.000435	0.00649	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CCNE1—ovarian cancer	0.000433	0.00645	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—ovarian cancer	0.000429	0.0064	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RSF1—ovarian cancer	0.000425	0.00634	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—MLH1—ovarian cancer	0.000424	0.00632	CbGpPWpGaD
Lucanthone—APEX1—Doxorubicin—Epirubicin—ovarian cancer	0.000423	0.158	CbGdCrCtD
Lucanthone—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.000409	0.152	CbGdCrCtD
Lucanthone—APEX1—S Phase—SKP2—ovarian cancer	0.000392	0.00584	CbGpPWpGaD
Lucanthone—APEX1—Epirubicin—Doxorubicin—ovarian cancer	0.000391	0.146	CbGdCrCtD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—CASP3—ovarian cancer	0.000366	0.00546	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000365	0.00544	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—GADD45A—ovarian cancer	0.000362	0.0054	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FASN—ovarian cancer	0.00035	0.00522	CbGpPWpGaD
Lucanthone—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.00035	0.13	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000334	0.00497	CbGpPWpGaD
Lucanthone—APEX1—Telomere Maintenance—TERT—ovarian cancer	0.000324	0.00483	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—BRCA1—ovarian cancer	0.000321	0.00479	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—VEGFA—ovarian cancer	0.000317	0.00473	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000313	0.00466	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000293	0.00436	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—BRCA2—ovarian cancer	0.000291	0.00433	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000283	0.00421	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—APC—ovarian cancer	0.000278	0.00415	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000274	0.00408	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000274	0.00408	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—ovarian cancer	0.000271	0.00404	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—TERT—ovarian cancer	0.00027	0.00402	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000269	0.00401	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCNE1—ovarian cancer	0.000263	0.00392	CbGpPWpGaD
Lucanthone—TOP2A—Vindesine—Vinorelbine—ovarian cancer	0.00026	0.0968	CbGdCrCtD
Lucanthone—TOP1—Circadian rythm related genes—TYMS—ovarian cancer	0.000258	0.00385	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RBL2—ovarian cancer	0.000253	0.00377	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MTOR—ovarian cancer	0.000239	0.00356	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—SKP2—ovarian cancer	0.000239	0.00356	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.000239	0.00356	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TOP1—ovarian cancer	0.000229	0.00341	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CDKN1B—ovarian cancer	0.000224	0.00334	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RAD51C—ovarian cancer	0.000223	0.00333	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	0.000218	0.00325	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TLR4—ovarian cancer	0.000213	0.00317	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000209	0.00311	CbGpPWpGaD
Lucanthone—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	0.000204	0.076	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle, Mitotic—RBL2—ovarian cancer	0.0002	0.00299	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PPP1CC—ovarian cancer	0.0002	0.00298	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—AKT1—ovarian cancer	0.000198	0.00295	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000197	0.00294	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RSF1—ovarian cancer	0.000197	0.00293	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PPP1CC—ovarian cancer	0.000195	0.00291	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—STAT3—ovarian cancer	0.000185	0.00275	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—CTNNB1—ovarian cancer	0.000179	0.00267	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RBL2—ovarian cancer	0.000179	0.00267	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MAPK3—ovarian cancer	0.000176	0.00263	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—HNF1B—ovarian cancer	0.000174	0.00259	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MYC—ovarian cancer	0.000172	0.00256	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—SKP2—ovarian cancer	0.000168	0.00251	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MAPK1—ovarian cancer	0.000168	0.0025	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—CDKN1B—ovarian cancer	0.000166	0.00248	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.00016	0.00239	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—ovarian cancer	0.000158	0.00235	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1B—ovarian cancer	0.000156	0.00232	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000153	0.00228	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—PIK3CA—ovarian cancer	0.000146	0.00217	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—MYC—ovarian cancer	0.000145	0.00217	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL8—ovarian cancer	0.000144	0.00215	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—ovarian cancer	0.000142	0.00212	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000142	0.00212	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDKN1B—ovarian cancer	0.000141	0.0021	CbGpPWpGaD
Lucanthone—TOP2A—Vincristine—Vinorelbine—ovarian cancer	0.00014	0.0522	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000139	0.00207	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CASP3—ovarian cancer	0.000138	0.00206	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL2—ovarian cancer	0.000138	0.00206	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1B—ovarian cancer	0.000136	0.00203	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000135	0.00202	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—HRAS—ovarian cancer	0.000135	0.00201	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCND1—ovarian cancer	0.000134	0.002	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000134	0.002	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—SKP2—ovarian cancer	0.000133	0.00199	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000131	0.00195	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MMP9—ovarian cancer	0.00013	0.00195	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCND1—ovarian cancer	0.00013	0.00194	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND2—ovarian cancer	0.000129	0.00192	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PTEN—ovarian cancer	0.000125	0.00187	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—PPP2R1A—ovarian cancer	0.000122	0.00181	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MLH1—ovarian cancer	0.000121	0.0018	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—ovarian cancer	0.000119	0.00178	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—SKP2—ovarian cancer	0.000119	0.00178	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—AKT1—ovarian cancer	0.000119	0.00177	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000118	0.00176	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000114	0.0017	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCNE1—ovarian cancer	0.000113	0.00168	CbGpPWpGaD
Lucanthone—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	0.000113	0.042	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000112	0.00166	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—TYMS—ovarian cancer	0.000111	0.00165	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MAPK3—ovarian cancer	0.000111	0.00165	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000109	0.00162	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MYC—ovarian cancer	0.000108	0.00161	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000106	0.00158	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000106	0.00158	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MAPK1—ovarian cancer	0.000105	0.00157	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—ovarian cancer	0.000105	0.00157	CbGpPWpGaD
Lucanthone—APEX1—S Phase—MYC—ovarian cancer	0.000104	0.00156	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000104	0.00155	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RAD51C—ovarian cancer	0.000103	0.00154	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND2—ovarian cancer	0.000102	0.00152	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	0.000101	0.00151	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.0001	0.0015	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	9.76e-05	0.00146	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CHEK2—ovarian cancer	9.75e-05	0.00145	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	9.64e-05	0.00144	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RBL2—ovarian cancer	9.27e-05	0.00138	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.22e-05	0.00137	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BRCA1—ovarian cancer	9.14e-05	0.00136	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND2—ovarian cancer	9.14e-05	0.00136	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PPP1CC—ovarian cancer	9.03e-05	0.00135	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCNE1—ovarian cancer	8.95e-05	0.00133	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.92e-05	0.00133	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—ovarian cancer	8.85e-05	0.00132	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	8.83e-05	0.00132	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TYMS—ovarian cancer	8.79e-05	0.00131	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PPP2R1A—ovarian cancer	8.62e-05	0.00129	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—ovarian cancer	8.56e-05	0.00128	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	8.55e-05	0.00128	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	8.55e-05	0.00128	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	8.4e-05	0.00125	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	8.31e-05	0.00124	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RBL2—ovarian cancer	8.29e-05	0.00124	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BRCA2—ovarian cancer	8.26e-05	0.00123	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL6—ovarian cancer	8.1e-05	0.00121	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TYMS—ovarian cancer	8.06e-05	0.0012	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCNE1—ovarian cancer	8e-05	0.00119	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	7.93e-05	0.00118	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—BIRC5—ovarian cancer	7.91e-05	0.00118	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TYMS—ovarian cancer	7.86e-05	0.00117	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—IL6—ovarian cancer	7.84e-05	0.00117	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.53e-05	0.00112	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BIRC5—ovarian cancer	7.07e-05	0.00105	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TERT—ovarian cancer	6.85e-05	0.00102	CbGpPWpGaD
Lucanthone—TOP2A—Idarubicin—Epirubicin—ovarian cancer	6.83e-05	0.0255	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	6.83e-05	0.0255	CbGdCrCtD
Lucanthone—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	6.83e-05	0.0255	CbGdCrCtD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	6.52e-05	0.000972	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	6.36e-05	0.000949	CbGpPWpGaD
Lucanthone—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	6.32e-05	0.0236	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	6.32e-05	0.0236	CbGdCrCtD
Lucanthone—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	6.32e-05	0.0236	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle, Mitotic—SKP2—ovarian cancer	6.17e-05	0.000919	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	6.16e-05	0.000919	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	5.85e-05	0.000872	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND1—ovarian cancer	5.58e-05	0.000832	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MLH1—ovarian cancer	5.58e-05	0.000831	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—SKP2—ovarian cancer	5.51e-05	0.000822	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	5.23e-05	0.000779	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	4.79e-05	0.000714	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND2—ovarian cancer	4.73e-05	0.000705	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	4.64e-05	0.000692	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CHEK2—ovarian cancer	4.51e-05	0.000672	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYC—ovarian cancer	4.48e-05	0.000668	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	4.46e-05	0.000665	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	4.43e-05	0.000661	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND1—ovarian cancer	4.43e-05	0.00066	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	4.34e-05	0.000648	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	4.23e-05	0.000631	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND2—ovarian cancer	4.23e-05	0.00063	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BRCA1—ovarian cancer	4.23e-05	0.00063	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	4.19e-05	0.000624	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1B—ovarian cancer	4.15e-05	0.000619	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	4.14e-05	0.000617	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	4.08e-05	0.000609	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—TYMS—ovarian cancer	4.07e-05	0.000606	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PPP2R1A—ovarian cancer	3.99e-05	0.000594	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND1—ovarian cancer	3.96e-05	0.00059	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PTEN—ovarian cancer	3.92e-05	0.000584	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BRCA2—ovarian cancer	3.82e-05	0.00057	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCNE1—ovarian cancer	3.7e-05	0.000552	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	3.69e-05	0.00055	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	3.66e-05	0.000545	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MAPK3—ovarian cancer	3.65e-05	0.000544	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TYMS—ovarian cancer	3.64e-05	0.000542	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYC—ovarian cancer	3.55e-05	0.000529	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	3.49e-05	0.00052	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MAPK1—ovarian cancer	3.47e-05	0.000518	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	3.39e-05	0.000506	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	3.32e-05	0.000495	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	3.32e-05	0.000495	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BIRC5—ovarian cancer	3.27e-05	0.000487	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MAPK3—ovarian cancer	3.26e-05	0.000487	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYC—ovarian cancer	3.17e-05	0.000473	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TERT—ovarian cancer	3.17e-05	0.000472	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	3.13e-05	0.000467	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MAPK1—ovarian cancer	3.11e-05	0.000463	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.88e-05	0.000429	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.79e-05	0.000415	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—ovarian cancer	2.67e-05	0.000399	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—ovarian cancer	2.61e-05	0.000389	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—IL6—ovarian cancer	2.45e-05	0.000365	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.35e-05	0.000351	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	2.15e-05	0.00032	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND1—ovarian cancer	2.05e-05	0.000305	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1B—ovarian cancer	1.92e-05	0.000286	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND1—ovarian cancer	1.83e-05	0.000273	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	1.69e-05	0.000252	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	1.64e-05	0.000245	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	1.61e-05	0.00024	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MAPK3—ovarian cancer	1.51e-05	0.000225	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYC—ovarian cancer	1.47e-05	0.000219	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MAPK1—ovarian cancer	1.44e-05	0.000214	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—ovarian cancer	1.21e-05	0.00018	CbGpPWpGaD
